Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 656-664

  Rakhit, Dhrubo J ^a   Zhang, Xiaohong H ^a   Leano, Rodel ^a   Armstrong, Kirsten A ^b   Isbel, Nicole M ^b   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; PHOSPHATE;

ADULT; ARTICLE; CARDIOMEGALY; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE VOLUME; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PREDICTION AND FORECASTING; PREDICTOR VARIABLE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; STRESS ECHOCARDIOGRAPHY; TISSUE CHARACTERIZATION; TREATMENT RESPONSE;

CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947323805     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.028     Document Type: Article

References (32)

1. Foley R.N., Parfrey P.S., Harnett J.D., et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5 (1995) 2024-2231
2. Parfrey P.S., Foley R.N., Harnett J.D., et al. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11 (1996) 1277-1285
3. Isbel N.M., Haluska B., Johnson D.W., et al. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J 151 (2006) 745-753
4. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
5. Rakhit D.J., Marwick T.H., Armstrong K.A., et al. Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart 92 (2006) 1402-1408
6. Herzog C.A., Li S., Weinhandl E.D., et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68 (2005) 818-825
7. Herzog C.A., Ma J.Z., and Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106 (2002) 2207-2211
8. Parfrey P.S., Harnett J.D., Foley R.N., et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60 (1995) 908-914
9. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 (1999) 1725-1730
10. Marwick T.H. Should we be evaluating the ventricle or the myocardium? Advances in tissue characterization. J Am Soc Echocardiogr 17 (2004) 168-172
11. Fang Z.Y., Yuda S., Anderson V., et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 41 (2003) 611-617
12. Yuda S., Short L., Leano R., et al. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Sci (Lond) 103 (2002) 283-293
13. Nagueh S.F., Bachinski L.L., Meyer D., et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104 (2001) 128-130
14. von Bibra H., Hansen A., Dounis V., et al. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 90 (2004) 1483-1484
15. Weidemann F., Breunig F., Beer M., et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108 (2003) 1299-1301
16. Foley R.N., Parfrey P.S., Kent G.M., et al. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11 (2000) 912-916
17. Rigatto C., Foley R.N., Kent G.M., et al. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 70 (2000) 570-575
18. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
19. Pritchett A.M., Jacobsen S.J., Mahoney D.W., et al. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 41 (2003) 1036-1043
20. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
21. Fang Z.Y., Najos-Valencia O., and Leano R. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol 42 (2003) 446-453
22. Sarnak M.J., and Levey A.S. Epidemiology of Cardiac Disease in Dialysis Patients. Seminars In Dialysis 12 (1999) 69-76
23. Amann K., Tornig J., Kugel B., et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63 (2003) 1296-1301
24. Mall G., Huther W., Schneider J., et al. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 5 (1990) 39-44
25. Vanholder R., Glorieux G., and Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 18 (2003) 463-466
26. Weisensee D., Schnaars Y., Schoeppe W., et al. Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro. Exp Nephrol 5 (1997) 194-200
27. Wang M., Yip G.W., Wang A.Y., et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41 (2003) 820-826
28. Wang M., Yip G.W., Wang A.Y., et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 23 (2005) 183-191
29. Marwick T.H., Case C., Leano R., et al. Use of tissue Doppler imaging to facilitate the prediction of events in patients with abnormal left ventricular function by dobutamine echocardiography. Am J Cardiol 93 (2004) 142-146
30. Hung K.C., Huang H.L., Chu C.M., et al. Evaluating preload dependence of a novel Doppler application in assessment of left ventricular diastolic function during hemodialysis. Am J Kidney Dis 43 (2004) 1040-1046
31. Graham R.J., Gelman J.S., Donelan L., et al. Effect of preload reduction by haemodialysis on new indices of diastolic function. Clin Sci (Lond) 105 (2003) 499-506
32. Yalcin F., Kaftan A., Muderrisoglu H., et al. Is Doppler tissue velocity during early left ventricular filling preload independent?. Heart 87 (2002) 336-339